ViroGates A/S

Research ViroGates A/S (VIRO) on Bullrun: market cap DKK 100.24M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerVIRO
ExchangeCO
CountryDenmark
SectorHealthcare
IndustryMedical Devices
CurrencyDKK
Market capDKK 100.24M
Financial periodQ1 2026
RevenueDKK 1.30M
Net income-DKK 2.61M
Free cash flow-DKK 3.74M
Gross margin74.9%

Valuation Snapshot

latest market cap is DKK 100.24M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	DKK 8.90M	-DKK 10.40M	-DKK 4.13M	74.4%	n/a	DKK 26.30M	DKK 4.62M	DKK 19.40M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-24	DKK 100.24M	n/a	n/a	n/a

About ViroGates A/S

ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic TurbiLatex, a CE-IVD approved particle-enhanced turbidimetric immunoassay for quantitative measurement of suPAR in human plasma; suPARnostic AUTO Flex ELISA kit, a fully quantitative immunoassay designed for accurate and reliable measurement of soluble urokinase plasminogen activator receptor in human plasma;

Related stock research

Denmark stocks Denmark Healthcare stocks A-Z stock index

Other Healthcare stocks

Ambu A/S (AMBU-B) ChemoMetec A/S (CHEMM) Demant A/S (DEMANT) GN Store Nord (GN) Scandinavian Medical Solutions AS (SMSMED) Strategic Partners A/S (1TB0) 2cureX AB (2CUREX) CESSATECH A/S DK -20 (8GN) FLUOGUIDE A/S DK -1 (96X) ALK-Abelló A/S (ALK-B) Ascendis Pharma A/S (ASND) BioPorto (BIOPOR)

Frequently asked questions

What is ViroGates A/S's market cap?

ViroGates A/S's market capitalization is DKK 100.24M.